Herrmann Ken
Director at AKTS
- Sold, on record
- $197k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Jul 20, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- AKTSAktis Oncology, Inc.Director
Sales by reason
0
Routine
0
Plan not stated
0
No plan
2
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice AKTSNoticeJul 17, 2026 2026
Filed to sell 3,065 shares ($77k)
Herrmann Ken, Director
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale AKTSUnusualJul 17, 2026 same day
Sold 3,065 shares at $25.21 ($77k)
Herrmann Ken, Director
No 10b5-1 planSold 100% of holdings ($77k position)0 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice AKTSNoticeJul 20, 2026 +3 days
Filed to sell 4,856 shares ($119k)
Herrmann Ken, Director
No 10b5-1 planFiling
- 4 Form 4 sale AKTSUnusualJul 20, 2026 same day
Sold 4,856 shares at $24.56 ($119k)
Herrmann Ken, Director
No 10b5-1 planSold 100% of holdings ($119k position)0 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2026 | Jul 21, 2026 | AKTS | Director | Form 4 sale | 4,856 | $119k | 100.0% | Unusual | SEC |
| Jul 20, 2026 | Jul 20, 2026 | AKTS | Director | Form 144 notice | 4,856 | $119k | Notice | SEC | |
| Jul 17, 2026 | Jul 20, 2026 | AKTS | Director | Form 4 sale | 3,065 | $77k | 100.0% | Unusual | SEC |
| Jul 17, 2026 | Jul 17, 2026 | AKTS | Director | Form 144 notice | 3,065 | $77k | Notice | SEC |